These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28093201)

  • 1. Molecular targets of the Warburg effect and inflammatory cytokines in the pathogenesis of pulmonary artery hypertension.
    Liu N; Parry S; Xiao Y; Zhou S; Liu Q
    Clin Chim Acta; 2017 Mar; 466():98-104. PubMed ID: 28093201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.
    Crosswhite P; Sun Z
    J Hypertens; 2010 Feb; 28(2):201-12. PubMed ID: 20051913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension: pathogenesis and clinical management.
    Thenappan T; Ormiston ML; Ryan JJ; Archer SL
    BMJ; 2018 Mar; 360():j5492. PubMed ID: 29540357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect.
    Cottrill KA; Chan SY
    Eur J Clin Invest; 2013 Aug; 43(8):855-65. PubMed ID: 23617881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?].
    Dumas SJ; Humbert M; Cohen-Kaminsky S
    Biol Aujourdhui; 2016; 210(4):171-189. PubMed ID: 28327277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.
    Wang J; Liu C; Huang SS; Wang HF; Cheng CY; Ma JS; Li RN; Lian TY; Li XM; Ma YJ; Jing ZC
    Eur J Pharmacol; 2024 May; 970():176492. PubMed ID: 38503401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Warburg effect: A new story in pulmonary arterial hypertension.
    Peng H; Xiao Y; Deng X; Luo J; Hong C; Qin X
    Clin Chim Acta; 2016 Oct; 461():53-8. PubMed ID: 27475978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
    Kayikçioğlu M
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary arterial hypertension: New pathophysiological insights and emerging therapeutic targets.
    Bourgeois A; Omura J; Habbout K; Bonnet S; Boucherat O
    Int J Biochem Cell Biol; 2018 Nov; 104():9-13. PubMed ID: 30189252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
    Plecitá-Hlavatá L; D'alessandro A; El Kasmi K; Li M; Zhang H; Ježek P; Stenmark KR
    Adv Exp Med Biol; 2017; 967():241-260. PubMed ID: 29047090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dynamics in pulmonary arterial hypertension.
    Ryan J; Dasgupta A; Huston J; Chen KH; Archer SL
    J Mol Med (Berl); 2015 Mar; 93(3):229-42. PubMed ID: 25672499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
    Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.
    Voelkel NF; Gomez-Arroyo J
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):474-84. PubMed ID: 24932885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic theory of pulmonary arterial hypertension.
    Paulin R; Michelakis ED
    Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators involved in HIV-related pulmonary arterial hypertension.
    Humbert M
    AIDS; 2008 Sep; 22 Suppl 3():S41-7. PubMed ID: 18845921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?
    Riou M; Enache I; Sauer F; Charles AL; Geny B
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory and immunosuppressive agents in PAH.
    Meloche J; Renard S; Provencher S; Bonnet S
    Handb Exp Pharmacol; 2013; 218():437-76. PubMed ID: 24092351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances.
    Mercurio V; Cuomo A; Naranjo M; Hassoun PM
    Compr Physiol; 2021 Apr; 11(2):1805-1829. PubMed ID: 33792903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.
    Liang S; Desai AA; Black SM; Tang H
    Adv Exp Med Biol; 2021; 1303():275-303. PubMed ID: 33788198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.